Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
Completed
- Conditions
- Allergy
- Registration Number
- NCT00461721
- Lead Sponsor
- University of Zurich
- Brief Summary
To find a test to elaborate a parameter for specific immunotherapy in allergic patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Age between 18 and 65
- Signed informed consent
- SIT 2000/2001
- 10 patients with SIT with a good result- 10 patients with bad results
Exclusion criteria:
- Pregnancy and breastfeeding
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cutaneous antigen neutralization in grass pollen immunotherapy for rhinoconjunctivitis?
How does cutaneous antigen neutralization testing compare to basophil activation assays in monitoring allergen-specific immunotherapy efficacy?
Which biomarkers correlate with successful grass pollen immunotherapy outcomes in rhinoconjunctivitis patients using cutaneous antigen neutralization tests?
What adverse events are associated with cutaneous antigen neutralization testing during grass pollen immunotherapy and how are they managed?
Are there combination approaches with cutaneous antigen neutralization tests and sublingual immunotherapy for grass pollen-induced rhinoconjunctivitis?
Trial Locations
- Locations (1)
Department of Dermatology
🇨🇭Zurich, Switzerland
Department of Dermatology🇨🇭Zurich, Switzerland